ASH Impact Series: Vincent Rajkumar, MD - Examining the New FDA Approved Myeloma Drug Products

7/10/2016

Description

Vincent Rajkumar, MD, discusses the three myeloma drugs that received FDA approval in November 2015 and how they will affect myeloma therapy. Dr. Rajkumar offered a clinical perspective on the new myeloma drugs at the "ASH/FDA Joint Symposium on Late-Breaking Drug Approvals" at the 57th ASH Annual Meeting. Visit https://ashondemand.org/ for more on this topic and to watch other educational videos from ASH.

Speakers

  • Vincent Rajkumar, MD

back to top